Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (11-20 of 405) with videos related to

Pageof 41
Sort By:
Onkologie|September 25, 2007
EGFR inhibitors in the treatment of lung cancerFred R Hirsch
Current Opinion in Oncology|February 24, 2005
Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancerFred R Hirsch, Samir Witta
Clinical Lung Cancer|May 27, 2008
Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspectiveRafal Dziadziuszko, Fred R Hirsch
Oncotargets and Therapy|September 14, 2016
Clinical potential of necitumumab in non-small cell lung carcinomaCarlo Genova, Fred R Hirsch
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Molecular approaches to lung cancer evaluationJacek Niklinski, Fred R Hirsch
Biologics : Targets & Therapy|May 3, 2014
Clinical and comparative utility of afatinib in non-small cell lung cancerManolo D'Arcangelo, Fred R Hirsch
Translational Lung Cancer Research|March 14, 2018
PACIFIC trial: new perspectives for immunotherapy in lung cancerFrancesco Agustoni, Fred R Hirsch
Oncology and Therapy|March 27, 2024
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A PodcastFred R Hirsch, Chul Kim
The Lancet. Oncology|March 29, 2012
A new generation of EGFR tyrosine-kinase inhibitors in NSCLCFred R Hirsch, Paul A Bunn
The Lancet. Oncology|May 5, 2009
EGFR testing in lung cancer is ready for prime timeFred R Hirsch, Paul A Bunn
Pageof 41

Showing results (11-20 of 405) with videos related to

Sort By:
Pageof 41
Onkologie|September 25, 2007
EGFR inhibitors in the treatment of lung cancerFred R Hirsch
Current Opinion in Oncology|February 24, 2005
Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancerFred R Hirsch, Samir Witta
Clinical Lung Cancer|May 27, 2008
Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspectiveRafal Dziadziuszko, Fred R Hirsch
Oncotargets and Therapy|September 14, 2016
Clinical potential of necitumumab in non-small cell lung carcinomaCarlo Genova, Fred R Hirsch
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Molecular approaches to lung cancer evaluationJacek Niklinski, Fred R Hirsch
Biologics : Targets & Therapy|May 3, 2014
Clinical and comparative utility of afatinib in non-small cell lung cancerManolo D'Arcangelo, Fred R Hirsch
Translational Lung Cancer Research|March 14, 2018
PACIFIC trial: new perspectives for immunotherapy in lung cancerFrancesco Agustoni, Fred R Hirsch
Oncology and Therapy|March 27, 2024
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A PodcastFred R Hirsch, Chul Kim
The Lancet. Oncology|March 29, 2012
A new generation of EGFR tyrosine-kinase inhibitors in NSCLCFred R Hirsch, Paul A Bunn
The Lancet. Oncology|May 5, 2009
EGFR testing in lung cancer is ready for prime timeFred R Hirsch, Paul A Bunn
Pageof 41